Sygnus Biotech Logo
CEFNUS-100
Rx Only
Ready for 24-48h Central Dispatch
In Stock

CEFNUS-100 Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download
TabletPrescription Required (Schedule Drug)

CEFNUS-100

5.0(1 review)
Verified Quality Batch
Active Drug Composition

Cefixime Dispersible Tablet 100mg

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

CEFNUS-100 is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.

Dosage FormTablet
Packaging Presentation10 x 10 Tablets
B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Lower Respiratory Tract Infections
Acute Bacterial Sinusitis
Urinary Tract Infections (UTI)
Skin and Soft Tissue Infections
Community-Acquired Pneumonia

Mechanism of Action (MOA)

Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.

Dosage & Posology

Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C in a dry place. Protect from moisture and direct sunlight.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentTablet
Dosage FormTablet
Packaging Type10 x 10 Tablets
Regulatory ScheduleSchedule H
Country of OriginIndia
Quality StandardWHO-GMP & ISO 9001:2015
Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

CEFNUS-100 features Cefixime Dispersible Tablet 100mg prepared to high pharmaceutical purity standards.

Therapeutic ClassificationTablet
Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Verified Practitioner & Distributor Feedback

Customer & Clinical Reviews

Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.

5.0

Based on 1 verified review

5
1 (100%)
4
0 (0%)
3
0 (0%)
2
0 (0%)
1
0 (0%)
Verified Feedback
20 May 2026

Endorsed by attending medical offic for CEFNUS-100

CEFNUS-100 has been endorsed by attending medical officers for dependable recovery, offering predictable therapeutic action that doctors in our territory rely upon daily. Sturdy outer cartons and individual pack serialization facilitate seamless inventory scanning. Continues to be a key prescription driver in our PCD pharma franchise portfolio.

Pradeep Jha•Ethical Pharma Distributor, Varanasi
Distributor Inquiries

Questions Regarding CEFNUS-100

What is the therapeutic indication and composition of CEFNUS-100?

CEFNUS-100 contains Cefixime Dispersible Tablet 100mg indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.

What packaging presentations are available for CEFNUS-100?

CEFNUS-100 is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for CEFNUS-100?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for CEFNUS-100 along with promotional visual aids, product cards, and marketing support.

What is the regulatory schedule and minimum order quantity (MOQ)?

CEFNUS-100 is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.

Related Formulations in Tablet

View all Tablet →
Tablet
LEZIL-DM

LEZIL-DM

Montelukast 10mg + Desloratadine 5mg

Pack:10 x 10 Tablets
Tablet
LEEVOXY-250

LEEVOXY-250

Levofloxacin 250mg

Pack:10 x 10 Tablets
Tablet
DAIBET-G2 V

DAIBET-G2 V

Glimepiride 2mg + Metformin Hydrochloride 500mg + Voglibose 0.2mg Bilayered

Pack:10 x 10 Tablets
Tablet
MEP-8

MEP-8

Methylprednisolone 8mg

Pack:10 x 10 Tablets
Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of CEFNUS-100

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.